Hexavalent vaccine DTaP/IPV/Hib/HepB: PGD template

PGD template for administering hexavalent vaccine following national recommendations and the routine childhood immunisation programme.

Applies to England


Hexavalent vaccine, DTaP/IPV/Hib/HepB: Patient Group Direction (PGD) template

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This patient group direction (PGD) template supports the administration of hexavalent vaccine, DTaP/IPV/Hib/HepB, in accordance with national recommendations and the routine childhood immunisation programme.

DTaP/IPV/Hib/HepB PGD v04.00version 5.00 is valid from 2524 July 20222024 to 24 JulyNovember 2024.2026

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and summary of product characteristics for the vaccine.

Published 31 July 2017
Last updated 2911 JulyJune 20222024 + show all updates
  1. Added version 5.00 see page 3 for change history.

  2. Added v04.00 – see page 2 for change history.

  3. Added updated PGD.

  4. Replaced PDG template with version v02.00, valid from 1 September 2019 to 31 August 2021.